Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease

NCT00206661 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Sargramostim (Leukine)
DRUG: Sargramostim (Leukine)

Sponsor

Genzyme, a Sanofi Company